These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36674031)

  • 1. Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis.
    Rohner H; Gaspar N; Philipsen A; Schulze M
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.
    Young JT; Carruthers S; Kaye S; Allsop S; Gilsenan J; Degenhardt L; van de Glind G; van den Brink W; Preen D
    Drug Alcohol Rev; 2015 Nov; 34(6):683-93. PubMed ID: 25790353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
    Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
    BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
    Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
    Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.
    van de Glind G; Van Emmerik-van Oortmerssen K; Carpentier PJ; Levin FR; Koeter MW; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu ET; Moggi F; Dom G; Demetrovics Z; Fatséas M; Schillinger A; Kapitány-Fövény M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; ; van den Brink W
    Int J Methods Psychiatr Res; 2013 Sep; 22(3):232-44. PubMed ID: 24022983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
    Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
    Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
    Simon N; Rolland B; Karila L
    Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
    Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
    Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Substance use disorders and ADHD: an overview of recent Dutch research].
    van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
    Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
    Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function.
    MacDonald B; Sadek J
    BMC Psychiatry; 2021 May; 21(1):251. PubMed ID: 33980212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
    Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
    Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.
    Catalá-López F; Ridao M; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
    Syst Rev; 2019 Feb; 8(1):49. PubMed ID: 30744675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
    Fatseas M; Debrabant R; Auriacombe M
    Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.
    Slobodin O
    Eur Addict Res; 2020; 26(4-5):283-294. PubMed ID: 32535592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.